Ghosh D K, Menon K M
Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor 48109.
Biochem J. 1987 Jun 1;244(2):471-9. doi: 10.1042/bj2440471.
The present studies investigated the specific binding of 125I-labelled high-density lipoprotein (125I-HDL) to plasma membranes. Golgi, rough endoplasmic reticulum and mitochondria/lysosomes, prepared from ovaries of rats injected with human choriogonadotropin (hCG) or 0.9% NaCl. Treatment in vivo with hCG resulted in 2-3-fold induction of 125I-HDL binding activity in all the subcellular organelles. The specific binding of HDL to various subcellular organelles was dependent on the amount of protein, lipoprotein concentration and incubation time. Equilibrium-binding studies revealed comparable Kd values (13-22 micrograms of HDL protein/ml) for HDL binding in all the subcellular organelles tested. Treatment with cycloheximide (2.0 mg/kg body wt.) before hCG administration abolished the induction of HDL receptors, suggesting the involvement of a protein-synthesis-dependent process in receptor induction. Analysis of equilibrium dissociation constants (Kd) for 125I-HDL binding in membranes from hCG-, cycloheximide-and saline-treated animals suggests that the increase in binding was due to an increase in the number of binding sites rather than a change in the affinity. Additionally, pretreatment with tunicamycin, an inhibitor of N-linked glycosylation, had no effect on hCG-mediated receptor induction, suggesting that glycosylation of the receptor may not be necessary for the interaction of HDL with its receptors.
本研究调查了¹²⁵I标记的高密度脂蛋白(¹²⁵I-HDL)与质膜的特异性结合。从注射人绒毛膜促性腺激素(hCG)或0.9%氯化钠的大鼠卵巢中制备高尔基体、粗面内质网和线粒体/溶酶体。体内用hCG处理导致所有亚细胞器中¹²⁵I-HDL结合活性诱导增加2至3倍。HDL与各种亚细胞器的特异性结合取决于蛋白质的量、脂蛋白浓度和孵育时间。平衡结合研究显示,在所有测试的亚细胞器中,HDL结合的Kd值相当(13 - 22微克HDL蛋白/毫升)。在给予hCG之前用环己酰亚胺(2.0毫克/千克体重)处理可消除HDL受体的诱导,表明受体诱导涉及蛋白质合成依赖性过程。对hCG、环己酰亚胺和盐水处理动物的膜中¹²⁵I-HDL结合的平衡解离常数(Kd)分析表明,结合增加是由于结合位点数量增加而非亲和力变化。此外,用N-连接糖基化抑制剂衣霉素预处理对hCG介导的受体诱导没有影响,表明受体的糖基化对于HDL与其受体的相互作用可能不是必需的。